What happens when true experts break down walls to speed up cancer cures?

In this episode of the Oncology Voice Network Podcast, host Dr. Kirk Shepard welcomes Rebecca Goldstein, VP of Strategy and Communications at OVN and a self-described “oncology lifer.” Dive into a raw, real-world conversation about the often-overlooked role of innovation partners in pushing oncology drug development forward.

Rebecca shares her journey from the lab bench to shaping cross-sector collaboration, revealing what sets innovation partners apart from traditional service providers. She and Dr. Shepard explore why transparent and timely communication isn’t just nice-to-have—it’s essential for real progress. They break down the high cost of information silos, why trust is a two-way street, and how the OVN community is opening new doors for experts, manufacturers, and innovators to learn from each other.

You’ll gain practical takeaways on building powerful, trust-based relationships that break through bureaucracy and accelerate patient impact, plus a behind-the-scenes look at the making of Voices of Oncology and how competition gave way to collaboration.

Ready to see how a new culture of partnership can transform cancer drug development? Tune in and join the conversation.